1
|
Durkin N, Pellegrini M, Karaluka V, Slater G, Leyden D, Eaton S, De Coppi P. Clinical translation of tissue-engineered oesophageal grafts: are patients ready for us? Pediatr Surg Int 2024; 40:291. [PMID: 39503787 PMCID: PMC11541389 DOI: 10.1007/s00383-024-05866-y] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Accepted: 10/18/2024] [Indexed: 11/09/2024]
Abstract
PURPOSE We sought to engage with expert patient/carers to understand attitudes towards use of tissue engineering (TE) for long-gap oesophageal atresia (OA). METHODS An in-person engagement event for 70 patients/parents was held by the OA patient group, TOFS. Attitudes towards TE were assessed before and after a talk on use of TE oesophagi in a pre-clinical OA model. Perceptions were assessed using a 5-point Likert scale (median [range]) and compared using Mann-Whitney test. RESULTS 43 attendees responded; 56% parents/caregivers, 21% patients, 7% healthcare workers, 16% unreported. Most (85%) had some awareness of TE but for 15%, it was a new concept. Attendees were receptive to TE; 89% reported no concerns about growth of their/child(s) cells in a lab and 61% reported no concerns about using animal products. Perceptions of TE significantly improved after the presentation from 4 (2-5, n = 32) to 5 (3-5, n = 28) p < 0.0001, and 96% would like to be involved in focus groups on development of a TE product for use in OA. CONCLUSION Input from key stakeholders is essential to introduction of TE constructs clinically. The overall response to TE constructs was positive, and informs development of an OA-specific focus group to guide translation.
Collapse
Affiliation(s)
- N Durkin
- Stem Cell and Regenerative Medicine Section, Developmental Biology and Cancer Research and Teaching Department, Zayed Centre for Research Into Rare Disease in Children, UCL Great Ormond Street Institute of Child Health, London, UK
- NIHR GOSH Biomedical Research Centre, Great Ormond Street Hospital, London, UK
| | - M Pellegrini
- Stem Cell and Regenerative Medicine Section, Developmental Biology and Cancer Research and Teaching Department, Zayed Centre for Research Into Rare Disease in Children, UCL Great Ormond Street Institute of Child Health, London, UK
- NIHR GOSH Biomedical Research Centre, Great Ormond Street Hospital, London, UK
- Research Area of Fetal, Neonatal, and Cardiological Sciences, Bambino Gesù Children Hospital, IRCCS, Rome, Italy
| | - V Karaluka
- NIHR GOSH Biomedical Research Centre, Great Ormond Street Hospital, London, UK
| | - G Slater
- Tracheo-Oesophageal Fistula Support (TOFS) Charity, Nottingham, UK
| | - D Leyden
- NIHR GOSH Biomedical Research Centre, Great Ormond Street Hospital, London, UK
| | - S Eaton
- Stem Cell and Regenerative Medicine Section, Developmental Biology and Cancer Research and Teaching Department, Zayed Centre for Research Into Rare Disease in Children, UCL Great Ormond Street Institute of Child Health, London, UK
- NIHR GOSH Biomedical Research Centre, Great Ormond Street Hospital, London, UK
| | - Paolo De Coppi
- Stem Cell and Regenerative Medicine Section, Developmental Biology and Cancer Research and Teaching Department, Zayed Centre for Research Into Rare Disease in Children, UCL Great Ormond Street Institute of Child Health, London, UK.
- NIHR GOSH Biomedical Research Centre, Great Ormond Street Hospital, London, UK.
- Great Ormond Street Hospital for Children, Specialist Neonatal and Paediatric Surgery, London, UK.
| |
Collapse
|
2
|
Ravn T, Sørensen MP, Capulli E, Kavouras P, Pegoraro R, Picozzi M, Saugstrup LI, Spyrakou E, Stavridi V. Public perceptions and expectations: Disentangling the hope and hype of organoid research. Stem Cell Reports 2023; 18:841-852. [PMID: 37001517 PMCID: PMC10147824 DOI: 10.1016/j.stemcr.2023.03.003] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 08/19/2022] [Revised: 03/01/2023] [Accepted: 03/02/2023] [Indexed: 04/03/2023] Open
Abstract
Organoid technologies are rapidly advancing and hold great potential and hope for disease modeling and clinical translational research. Still, they raise a number of complex, ethical questions regarding their current and future use. Patient and public involvement is important in building public trust and helping to secure responsible conduct and valued innovations; nevertheless, research into patient and public perspectives on organoid technologies remains scarce. We report on a first public dialogue on organoid technologies through three cross-country deliberative workshops with a diverse group of stakeholders to identify their perceptions and concerns. Participants generally support organoid technologies on the condition that responsible governance, ethical oversight, and sound informed consent procedures are in place. Yet, a broad set of potential concerns are identified, primarily concerning commercialization, healthcare access, and cerebral organoids. Participants' insights and recommendations can help inform researchers and ethics and policy bodies toward supporting responsible and ethical organoid approaches.
Collapse
|
3
|
Fox G, Fergusson DA, Daham Z, Youssef M, Foster M, Poole E, Sharif A, Richards DP, Hendrick K, Mendelson AA, Macala KF, Monfaredi Z, Montroy J, Fiest KM, Presseau J, Lalu MM. Patient engagement in preclinical laboratory research: A scoping review. EBioMedicine 2021; 70:103484. [PMID: 34280783 PMCID: PMC8318845 DOI: 10.1016/j.ebiom.2021.103484] [Citation(s) in RCA: 24] [Impact Index Per Article: 6.0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 01/25/2021] [Revised: 06/24/2021] [Accepted: 06/25/2021] [Indexed: 02/01/2023] Open
Abstract
BACKGROUND 'Patient engagement' involves meaningful collaboration between researchers and 'patient partners' to co-create research. It helps ensure that research being conducted is relevant to its ultimate end-users. Although patient engagement within clinical research has been well documented, the prevalence and effects of patient engagement in translational preclinical laboratory research remain unclear. The aim of this scoping review is to present current patient engagement activities reported in preclinical laboratory research. METHODS MEDLINE, Embase, and grey literature were systematically searched from inception to April 2021. Studies that described or investigated patient engagement in preclinical laboratory research were included. Patient engagement activities where patients (i.e. patients, family members, caregivers or community members) provided input, or consultation on at least one element of the research process were eligible for inclusion. Study characteristics and outcomes were extracted and organized thematically. FINDINGS 32 reports were included (30 primary studies, 1 narrative review, and 1 researcher guide). Most studies engaged patients at the education or priority setting stages (n=26). The most frequently reported benefit of patient engagement was 'providing a mutual learning opportunity'. Reported barriers to patient engagement reflected concerns around 'differences in knowledge and research experience' and how this may challenge communication and limit meaningful collaboration. INTERPRETATION Patient engagement is feasible and beneficial for preclinical laboratory research. Future work should focus on assessing the impacts of patient engagement in this area of research. FUNDING None.
Collapse
Affiliation(s)
- Grace Fox
- Clinical Epidemiology Program, Blueprint Translational Research Group, Ottawa Hospital Research Institute, 501 Smyth Road, PO Box 201B, Ottawa, Ontario K1H 8L6, Canada
| | - Dean A. Fergusson
- Clinical Epidemiology Program, Blueprint Translational Research Group, Ottawa Hospital Research Institute, 501 Smyth Road, PO Box 201B, Ottawa, Ontario K1H 8L6, Canada
- School of Epidemiology and Public Health, University of Ottawa, Canada
- Faculty of Medicine, University of Ottawa, Canada
| | - Zeinab Daham
- Clinical Epidemiology Program, Blueprint Translational Research Group, Ottawa Hospital Research Institute, 501 Smyth Road, PO Box 201B, Ottawa, Ontario K1H 8L6, Canada
- Ottawa Stroke Program, Ottawa Hospital Research Institute, Canada
| | - Mark Youssef
- Faculty of Medicine, University of Ottawa, Canada
| | - Madison Foster
- Clinical Epidemiology Program, Blueprint Translational Research Group, Ottawa Hospital Research Institute, 501 Smyth Road, PO Box 201B, Ottawa, Ontario K1H 8L6, Canada
| | - Evelyn Poole
- Clinical Epidemiology Program, Blueprint Translational Research Group, Ottawa Hospital Research Institute, 501 Smyth Road, PO Box 201B, Ottawa, Ontario K1H 8L6, Canada
| | - Ayni Sharif
- Clinical Epidemiology Program, Blueprint Translational Research Group, Ottawa Hospital Research Institute, 501 Smyth Road, PO Box 201B, Ottawa, Ontario K1H 8L6, Canada
| | | | | | - Asher A. Mendelson
- Section of Critical Care Medicine, Department of Medicine, Rady Faculty of Health Sciences, University of Manitoba, Canada
| | - Kimberly F. Macala
- Department of Critical Care Medicine, Royal Alexandra Hospital, University of Alberta, Canada
- Department of Anaesthesiology and Pain Medicine, Royal Alexandra Hospital, University of Alberta, Canada
| | | | - Joshua Montroy
- Clinical Epidemiology Program, Blueprint Translational Research Group, Ottawa Hospital Research Institute, 501 Smyth Road, PO Box 201B, Ottawa, Ontario K1H 8L6, Canada
| | - Kirsten M. Fiest
- Department of Critical Care Medicine, Cumming School of Medicine, University of Calgary & Alberta Health Services, Canada
| | - Justin Presseau
- Clinical Epidemiology Program, Blueprint Translational Research Group, Ottawa Hospital Research Institute, 501 Smyth Road, PO Box 201B, Ottawa, Ontario K1H 8L6, Canada
- School of Epidemiology and Public Health, University of Ottawa, Canada
- School of Psychology, University of Ottawa, Canada
| | - Manoj M. Lalu
- Clinical Epidemiology Program, Blueprint Translational Research Group, Ottawa Hospital Research Institute, 501 Smyth Road, PO Box 201B, Ottawa, Ontario K1H 8L6, Canada
- Department of Anaesthesiology and Pain Medicine, The Ottawa Hospital, Canada
| |
Collapse
|
5
|
Gao W, Ma GX, Tan Y, Fang C, Weaver J, Jin M, Lai P. Factors associated with willingness to participate in biospecimen research among Chinese Americans. Biopreserv Biobank 2014; 12:131-8. [PMID: 24749880 PMCID: PMC3995351 DOI: 10.1089/bio.2013.0081] [Citation(s) in RCA: 20] [Impact Index Per Article: 1.8] [Reference Citation Analysis] [Abstract] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/25/2022] Open
Abstract
A paucity of information exists on the recruitment of Asian Americans for biospecimen research. Although studies show that Chinese Americans are at high risk for hepatitis B virus (HBV) infection, little is known about their willingness to participate in HBV-related biospecimen research and how knowledge, attitudes, and cultural factors impact their willingness to participate. The study was guided by Community-Based Participatory Research principles. Data were derived from an assessment study on HBV-related biospecimen research participation among Chinese Americans in the Philadelphia region. The assessment was conducted with 415 Chinese Americans recruited from eight Chinese community-based organizations. Cultural beliefs, knowledge, and attitudes toward biospecimen research were examined for associations with their willingness to participate in biospecimen banking research. Overall, 192 (46.3%) of 415 participants who completed the assessment indicated they were willing to participate if they were invited to donate blood to be frozen and stored for future HBV biospecimen studies. Cultural variables significant in bivariate analysis included collectivism, knowledge about biospecimen research, and Yin-Yang beliefs. Fatalism and individualism were not associated with participation willingness. In multivariate analysis, age, health care attitudes, and trust were significantly associated with willingness to participate in biospecimen banking research. Asian American communities have little knowledge of biospecimen banking and will benefit from educational campaigns that emphasize collective benefits and attitudes towards and trust in the health care system. Understanding cultural factors is important for improving Chinese Americans' knowledge, awareness, and intentions of participation in biospecimen research. Similar efforts need to be undertaken to develop culturally appropriate educational intervention programs to increase participation in biospecimen research among other Asian American groups.
Collapse
Affiliation(s)
- Wanzhen Gao
- Center for Asian Health, College of Health Professions, Temple University, Philadelphia, Pennsylvania
| | - Grace X. Ma
- Center for Asian Health, College of Health Professions, Temple University, Philadelphia, Pennsylvania
- Department of Public Health, College of Health Professions, Temple University, Philadelphia, Pennsylvania
| | - Yin Tan
- Center for Asian Health, College of Health Professions, Temple University, Philadelphia, Pennsylvania
| | - Carolyn Fang
- Cancer Prevention and Control, Fox Chase Cancer Center, Philadelphia, Pennsylvania
| | - JoEllen Weaver
- Biosample Repository, Fox Chase Cancer Center, Philadelphia, Pennsylvania
| | - Ming Jin
- Department of Pathology and Laboratory Medicine, Temple University Hospital and School of Medicine, Philadelphia, Pennsylvania
| | - Philip Lai
- Philadelphia Senior Center, Philadelphia, Pennsylvania
| |
Collapse
|